Increasing Incidence of Eye Diseases to Drive Global Corneal Transplantation Market

According to our new research study on "Corneal transplantation Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Type, Indication, and End User" the market is expected to grow from US$ 420.71 million in 2021 to US$ 640.79 million by 2028; it is estimated to grow at a CAGR of 6.2% during 2021-2028. Factors driving the growth of the market are the increasing incidence of eye diseases and surge in geriatric population.

Corneal blindness has complex epidemiology that includes a broad spectrum of infectious and inflammatory eye diseases causing corneal scars that contribute to functional blindness. According to the World Health Organization (WHO), 146 million people have trachoma, of which 10 million have trichiasis and require surgeries to prevent corneal blindness. In addition, ~4.9 million are completely blind due to trachomatous corneal scarring. According to 2020 statistics from the Cornea Research Foundation of America, keratoconus disorder affects ~50-200 out of every 100,000 people. As per the WHO, in 2021, ~2.2 billion people had near or far visual impairments-including 4.2 million people with corneal opacities. Thus, the growing incidence of eye diseases is bolstering the growth of the corneal transplantation market.

CorneaGen, Alcon Inc., Florida Lions Eye Bank, Corneat Vision, Aurolab, Keramed, Inc., Cornea Biosciences, Inc., Eyemedics, Massachusetts Eye and Ear, Lifeline Scientific, Inc., and San Diego Eye Bank are among the leading companies operating in the corneal transplantation market.

Based on type, corneal transplantation market is segmented into penetrating keratoplasty, Descemet Membrane Endothelial Keratoplasty (DMEK), Descemet Stripping Endothelial Keratoplasty (DSEK), Corneal Limbal Stem Cell Transplant, and others. Based on indication the market is segmented into fungal corneal ulcer, Fuchs dystrophy, keratoconus, keratitis, and others. Based on end user, the market is segmented into hospitals, eye clinics, and ambulatory surgical centers. By geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South and Central America (Brazil, Argentina, and the Rest of SCAM).

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com